Perthera, Inc. Announces the Appointment of Gary L. Gregory as Chief Executive Officer, President and Board Member
Mr. Gregory is recognized as a proven executive leader with big company capabilities and a keen start-up mindset, and his achievements include executing a successful IPO, driving substantial revenue & earning multiples for a publicly traded company, marshalling medical technologies through positive M&A efforts, and generating $50M+ in corporate financing efforts. - February 04, 2019
Perthera to Exhibit at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Perthera, Inc., the leading Therapeutics Intelligence Company™, is attending the 2018 ASCO Annual Meeting at McCormick Place, Chicago, IL, June 1-5, 2018. Perthera science and clinical results will be represented in a Podium Presentation, 2 Poster Presentations and a Symposium Breakfast. - May 30, 2018
Perthera Hosts Breakfast Symposium at the 2018 ASCO Annual Meeting
Perthera, Inc., the leading Therapeutics Intelligence Company™, will be hosting a networking breakfast and educational session on Monday, June 4th from 6:30 – 7:30 a.m. for attendees of the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. The breakfast symposium will be... - May 22, 2018
Perthera Inc. and Blue Faery Announce Their Partnership Against Liver Cancer
Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to provide liver cancer patients with therapeutic treatment options precisely matched to their individual... - February 20, 2018
Perthera and ZERO Announce the Decode Your Prostate Cancer Program
Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with ZERO, the leading nonprofit prostate cancer advocacy group in the USA, to form and launch the nationwide Decode Your Prostate Cancer program aimed to provide each prostate cancer patient with... - November 28, 2017
Perthera's Subha Madhavan, PhD, to Speak at Prestigious Health 2.0 Conference
Perthera Inc.’s, Subha Madhavan, PhD, Chief Bioinformatics Officer, will be speaking at the 11th Annual Fall Conference of Health 2.0 on Healthcare Innovations, Oct 1 - 4 in Santa Clara, CA, in the Personalized Health Track “Turning Data into Value.” Dr. Madhavan will present a... - September 26, 2017